# A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential

> **NCT04934696** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 25 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986166
- **DRUG:** Oral contraceptive

## Key facts

- **NCT ID:** NCT04934696
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-03
- **Primary completion:** 2022-01-25
- **Final completion:** 2022-01-25
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04934696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04934696, "A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04934696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*